NCT02223208 2025-12-02
FIL_PTCL13
Fondazione Italiana Linfomi - ETS
Phase 1/2 Active not recruiting
Clinical Trials
6 trialsNCT01947140 2022-11-23
PDX+Romi
Columbia University
Phase 1/2 Completed
NCT03141203 2022-05-18
RomiCar
University of Birmingham
Phase 1/2 Completed
NCT03547700 2021-01-19
Study of Ixazomib and Romidepsin in Peripheral T-cell Lymphoma (PTCL)
Big Ten Cancer Research Consortium
Phase 1/2 Active not recruiting
NCT01456039 2019-02-11
A Japanese Phase 1/2 Study to Assess the Efficacy, Safety and Pharmacokinetics of Romidepsin in Patients With Peripheral T-cell Lymphoma (PTCL)
Celgene
Phase 1/2 Completed
NCT01280526 2014-05-22
Ro-CHOP
The Lymphoma Academic Research Organisation
Phase 1/2 Completed